Modulation of UDP-Glucuronosyltransferase Activity by Endogenous Compounds

被引:28
作者
Ishii, Yuji [1 ]
Nurrochmad, Arief [1 ]
Yamada, Hideyuki [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
UDP-glucuronosyltransferase; fatty acyl-CoA; fatty acid; inhibitor; activator; adenine; NADP; NAD; ATP; CHAIN ACYL-COA; PROTEIN-PROTEIN INTERACTIONS; DRUG-METABOLIZING-ENZYMES; ACTIVATED RECEPTOR-ALPHA; HUMAN LIVER-MICROSOMES; ACID-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; URIDINE-DIPHOSPHATE; RAT-LIVER; IN-VITRO;
D O I
10.2133/dmpk.25.134
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucuronidation is one of the major pathways of metabolism of endo- and xenobiotics UDP-Glucuronosyltransferase (UGT)-catalyzed glucuronidation accounts for up to 35% of phase II reactions The expression and function of UGT is modulated by gene regulation, post-translational modifications and protein-protein association Many studies have focused on drug-drug interactions involving UGT. and there are a number of reports describing the inhibition of UGT by xenobiotics. However, studies about the role of endogenous compounds as an inhibitor or activator of UGT are limited, and it is important to understand any change in the function and regulation of UGT by endogenous compounds Recent studies in our laboratory have shown that fatty acyl-CoAs are endogenous activators of UGT, although fatty acyl-CoAs had been considered as inhibitors of UGT Further, we have also suggested that adenine and related compounds are endogenous allosteric inhibitors of UGT In this review, we summarize the endogenous modulators of UGT and discuss their relevance to UGT function
引用
收藏
页码:134 / 148
页数:15
相关论文
共 147 条
[1]  
AGARWAL AK, 1989, J BIOL CHEM, V264, P18939
[2]   Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers [J].
Aueviriyavit, Sasitorn ;
Furihata, Tomomi ;
Morimoto, Kaori ;
Kobayashi, Kaoru ;
Chiba, Kan .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (05) :391-398
[3]   LIPID-METABOLIZING ENZYMES, COASH AND LONG-CHAIN ACYL-COA IN RAT-LIVER AFTER TREATMENT WITH TIADENOL, NICOTINIC-ACID AND NIADENATE [J].
BAKKE, OM ;
BERGE, RK .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (23) :3930-3933
[4]   N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes [J].
Barbier, O ;
Girard, C ;
Breton, R ;
Bélanger, A ;
Hum, DW .
BIOCHEMISTRY, 2000, 39 (38) :11540-11552
[5]  
Barbier O, 2000, DRUG METAB DISPOS, V28, P497
[6]   The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor α and γ target gene [J].
Barbier, O ;
Villeneuve, L ;
Bocher, V ;
Fontaine, C ;
Torra, IP ;
Duhem, C ;
Kosykh, V ;
Fruchart, JC ;
Guillemette, C ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13975-13983
[7]   The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C [J].
Basu, Nikhil K. ;
Kole, Labanyamoy ;
Basu, Mousumi ;
Chakraborty, Kushal ;
Mitra, Partha S. ;
Owens, Ida S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (34) :23048-23061
[8]   Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity [J].
Basu, NK ;
Kovarova, M ;
Garza, A ;
Kubota, S ;
Saha, T ;
Mitra, PS ;
Banerjee, R ;
Rivera, J ;
Owens, IS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (18) :6285-6290
[9]  
BOSMA PJ, 1994, J BIOL CHEM, V269, P17960
[10]   MECHANISM OF STIMULATION OF MICROSOMAL UDP-GLUCURONOSYLTRANSFERASE BY UDP-N-ACETYLGLUCOSAMINE [J].
BOSSUYT, X ;
BLANCKAERT, N .
BIOCHEMICAL JOURNAL, 1995, 305 :321-328